Abstract

Activation of Toll like receptors (TLR) plays an important role in cardiovascular disease development, progression and outcomes. Complex TLR mediated signaling affects vascular and cardiac function including tissue remodeling and repair. Being central components of both innate and adaptive arms of the immune system, TLRs interact as pattern recognition receptors with a series of exogenous ligands and endogenous molecules or so-called danger associated molecular patterns (DAMPs) that are released upon tissue injury and cellular stress. Besides immune cells, a number of structural cells within the cardiovascular system, including endothelial cells, smooth muscle cells, fibroblasts and cardiac myocytes express TLRs and are able to release or sense DAMPs. Local activation of TLR-mediated signaling cascade induces cardiovascular tissue repair but in a presence of constant stimuli can overshoot and cause chronic inflammation and tissue damage. TLR accessory molecules are essential in guiding and dampening these responses toward an adequate reaction. Furthermore, accessory molecules assure specific and exclusive TLR-mediated signal transduction for distinct cells and pathways involved in the pathogenesis of cardiovascular diseases. Although much has been learned about TLRs activation in cardiovascular remodeling, the exact role of TLR accessory molecules is not entirely understood. Deeper understanding of the role of TLR accessory molecules in cardiovascular system may open therapeutic avenues aiming at manipulation of inflammatory response in cardiovascular disease. The present review outlines accessory molecules for membrane TLRs that are involved in cardiovascular disease progression. We first summarize the up-to-date knowledge on TLR signaling focusing on membrane TLRs and their ligands that play a key role in cardiovascular system. We then survey the current evidence of the contribution of TLRs accessory molecules in vascular and cardiac remodeling including myocardial infarction, heart failure, stroke, atherosclerosis, vein graft disease and arterio-venous fistula failure.

Highlights

  • Reviewed by: Esther Lutgens, Academic Medical Center, Netherlands Caroline Genco, Tufts University School of Medicine, United States

  • Being central components of both innate and adaptive arms of the immune system, Tolllike receptors (TLRs) interact as pattern recognition receptors with a series of exogenous ligands and endogenous molecules or so-called danger associated molecular patterns (DAMPs) that are released upon tissue injury and cellular stress

  • Not even three decades have passed since the discovery of TLR, this field has rapidly evolved and its importance was underscored by the Nobel Prize in Medicine in 2011

Read more

Summary

CARDIOVASCULAR DISEASE

Upon cardiovascular tissue injury a number of self-derived immunomodulatory molecules are released into the systemic circulation and the interstitial space where they act as damage associated molecular patterns (DAMPs) called alarmins. Immune responses, culminating in activation of transcription factors and subsequent production of pro-inflammatory cytokines and type I interferons These downstream pathways include positive feedback loops which can culminate in a strong response that can induce repair of tissue damage but can overshoot and with that cause acute and chronic inflammation such as atherosclerosis. CLRs are increasingly recognized as PRRs that are important in host defense against pathogens and can recognize number of DAMPs in the progression of cancer, CVD and autoimmune diseases [26, 27]. It is a large family of more than 1,000 proteins that have been placed into 17 groups based on their structure and/or function. In further sections of this review, we will discuss key characteristics of TLRs, with a particular focus of the role of TLRs and their accessory molecules in the development of cardiovascular-related pathologies

TLR FAMILY AND PATHWAY SIGNALING
Endogenous Ligands
FROM TLR LIGAND RECOGNITION TO SIGNAL TRANSDUCTION IN CVD
TLR LIGANDS
TLR SIGNALING
CELL SURFACE ACCESSORY MOLECULES IN CARDIOVASCULAR DISEASE PROGRESSION
CLUSTER OF DIFFERENTIATION
CROSSTALK FUNCTION
CONCLUDING REMARKS AND THERAPEUTIC PERSPECTIVES
Findings
AUTHOR CONTRIBUTIONS

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.